These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 21229879)
1. Inhibition of DNA topoisomerases I and II by G3 PAMAM-NH2 dendrimer-modified digoxin and proscillaridin A conjugates in a cell free system. Winnicka K; Bielawska A; Bielawski K Acta Pol Pharm; 2010; 67(6):630-4. PubMed ID: 21229879 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxic activity of G3 PAMAM-NH(2) dendrimer-modified digoxin and proscillaridin A conjugates in breast cancer cells. Winnicka K; Bielawski K; Bielawska A Pharmacol Rep; 2010; 62(2):414-23. PubMed ID: 20508299 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. Bielawski K; Winnicka K; Bielawska A Biol Pharm Bull; 2006 Jul; 29(7):1493-7. PubMed ID: 16819197 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of friedelan triterpenoid analogs with DNA topoisomerase IIα inhibitory activity and their molecular docking studies. Mandal A; Ghosh S; Bothra AK; Nanda AK; Ghosh P Eur J Med Chem; 2012 Aug; 54():137-43. PubMed ID: 22633831 [TBL] [Abstract][Full Text] [Related]
5. A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation. Shapiro AB; Austin CA Anal Biochem; 2014 Mar; 448():23-9. PubMed ID: 24309019 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of ferrocene derivatives on the catalytic activity of topoisomerase IIalpha and beta--distinct mode of action of two derivatives. Sai Krishna AD; Panda G; Kondapi AK Arch Biochem Biophys; 2005 Jun; 438(2):206-16. PubMed ID: 15907782 [TBL] [Abstract][Full Text] [Related]
7. A high-throughput-compatible, fluorescence anisotropy-based assay for ATP-dependent supercoiled DNA relaxation by human topoisomerase IIα. Shapiro AB Biochem Pharmacol; 2013 May; 85(9):1269-77. PubMed ID: 23415903 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of a novel series of pyranonaphthoquinones as topoisomerase II catalytic inhibitors. Jiménez-Alonso S; Orellana HC; Estévez-Braun A; Ravelo AG; Pérez-Sacau E; Machín F J Med Chem; 2008 Nov; 51(21):6761-72. PubMed ID: 18816045 [TBL] [Abstract][Full Text] [Related]
9. DNA-binding, topoisomerases I and II inhibition and in vitro cytotoxicity of ruthenium(II) polypyridyl complexes: [Ru(dppz)2L](2+) (L=dppz-11-CO2Me and dppz). He X; Jin L; Tan L Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():101-9. PubMed ID: 25062055 [TBL] [Abstract][Full Text] [Related]
10. A three-dimensional quantitative structure-activity relationship study of the inhibition of the ATPase activity and the strand passing catalytic activity of topoisomerase IIalpha by substituted purine analogs. Jensen LH; Liang H; Shoemaker R; Grauslund M; Sehested M; Hasinoff BB Mol Pharmacol; 2006 Nov; 70(5):1503-13. PubMed ID: 16880287 [TBL] [Abstract][Full Text] [Related]
11. [DNA supercoiling and topoisomerases in Escherichia coli]. Gómez-Eichelmann MC; Camacho-Carranza R Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348 [TBL] [Abstract][Full Text] [Related]
12. Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts. Winnicka K; Bielawski K; Bielawska A; Miltyk W Nat Prod Res; 2010 Feb; 24(3):274-85. PubMed ID: 20140806 [TBL] [Abstract][Full Text] [Related]
13. Further constituents of Galianthe thalictroides (Rubiaceae) and inhibition of DNA topoisomerases I and IIα by its cytotoxic β-carboline alkaloids. de Oliveira Figueiredo P; Perdomo RT; Garcez FR; de Fatima Cepa Matos M; de Carvalho JE; Garcez WS Bioorg Med Chem Lett; 2014 Mar; 24(5):1358-61. PubMed ID: 24507920 [TBL] [Abstract][Full Text] [Related]
14. Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain. McClendon AK; Gentry AC; Dickey JS; Brinch M; Bendsen S; Andersen AH; Osheroff N Biochemistry; 2008 Dec; 47(50):13169-78. PubMed ID: 19053267 [TBL] [Abstract][Full Text] [Related]
15. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs. Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121 [TBL] [Abstract][Full Text] [Related]
16. Disulfiram is a potent in vitro inhibitor of DNA topoisomerases. Yakisich JS; Sidén A; Eneroth P; Cruz M Biochem Biophys Res Commun; 2001 Nov; 289(2):586-90. PubMed ID: 11716515 [TBL] [Abstract][Full Text] [Related]
17. Dihydroxylated 2,4,6-triphenyl pyridines: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study. Karki R; Thapa P; Yoo HY; Kadayat TM; Park PH; Na Y; Lee E; Jeon KH; Cho WJ; Choi H; Kwon Y; Lee ES Eur J Med Chem; 2012 Mar; 49():219-28. PubMed ID: 22318164 [TBL] [Abstract][Full Text] [Related]
18. Ruthenium(II) polypyridyl complexes with 1,8-naphthalimide group as DNA binder, photonuclease, and dual inhibitors of topoisomerases I and IIα. Sun Y; Li J; Zhao H; Tan L J Inorg Biochem; 2016 Oct; 163():88-94. PubMed ID: 27470011 [TBL] [Abstract][Full Text] [Related]
19. A study of the topoisomerase II activity in HIV-1 replication using the ferrocene derivatives as probes. Kondapi AK; Satyanarayana N; Saikrishna AD Arch Biochem Biophys; 2006 Jun; 450(2):123-32. PubMed ID: 16712776 [TBL] [Abstract][Full Text] [Related]
20. [Poisons of DNA topoisomerases I and II]. Charcosset JY; Soues S; Laval F Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]